BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8425483)

  • 1. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Lilley K; Larner J; Hansen BC
    Endocrinology; 1993 Feb; 132(2):640-5. PubMed ID: 8425483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen phosphorylase activity and glycogen concentration in muscle of normal to overtly diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Varghese SS; Hansen BC
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):98-105. PubMed ID: 8646258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.
    Ortmeyer HK; Huang LC; Zhang L; Hansen BC; Larner J
    Endocrinology; 1993 Feb; 132(2):646-51. PubMed ID: 8425484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of skeletal muscle glucose 6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Hansen BC
    Diabetologia; 1994 Feb; 37(2):127-33. PubMed ID: 8163045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.
    Kennington AS; Hill CR; Craig J; Bogardus C; Raz I; Ortmeyer HK; Hansen BC; Romero G; Larner J
    N Engl J Med; 1990 Aug; 323(6):373-8. PubMed ID: 2370888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue glycogen synthase activation by in vivo insulin in spontaneously insulin-resistant and type 2 (non-insulin-dependent) diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Hansen BC
    Diabetologia; 1993 Mar; 36(3):200-6. PubMed ID: 8462768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies.
    Huang Z; Bodkin NL; Ortmeyer HK; Zenilman ME; Webster NJ; Hansen BC; Shuldiner AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1552-6. PubMed ID: 8636366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?
    Bodkin NL; Hannah JS; Ortmeyer HK; Hansen BC
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):53-61. PubMed ID: 8383642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys.
    Ortmeyer HK
    J Nutr; 2001 Mar; 131(3):907S-912S. PubMed ID: 11238784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin unexpectedly increases the glucose 6-phosphate Ka of skeletal muscle glycogen synthase in calorie-restricted monkeys.
    Ortmeyer HK; Huang L; Larner J; Hansen BC
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):309-23. PubMed ID: 10212841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Hansen BC
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R552-8. PubMed ID: 8214144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.
    Huang Z; Bodkin NL; Ortmeyer HK; Hansen BC; Shuldiner AR
    J Clin Invest; 1994 Sep; 94(3):1289-96. PubMed ID: 8083370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.
    Huang LC; Fonteles MC; Houston DB; Zhang C; Larner J
    Endocrinology; 1993 Feb; 132(2):652-7. PubMed ID: 8425485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin decreases skeletal muscle cAMP-dependent protein kinase (PKA) activity in normal monkeys and increases PKA activity in insulin-resistant rhesus monkeys.
    Ortmeyer HK
    J Basic Clin Physiol Pharmacol; 1997; 8(4):223-35. PubMed ID: 9651796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A thiazolidinedione improves in vivo insulin action on skeletal muscle glycogen synthase in insulin-resistant monkeys.
    Ortmeyer HK; Bodkin NL; Haney J; Yoshioka S; Horikoshi H; Hansen BC
    Int J Exp Diabetes Res; 2000; 1(3):195-202. PubMed ID: 11467410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical phosphorylation of skeletal muscle glycogen synthase by in vivo insulin in very lean young adult rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Hansen BC
    Ann N Y Acad Sci; 1999 Nov; 892():247-60. PubMed ID: 10842666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance.
    Larner J
    Int J Exp Diabetes Res; 2002; 3(1):47-60. PubMed ID: 11900279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
    Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
    J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.